Name:
Phenadoxone
Type:
Opioid
AKA:
N/A
Phenadoxone image
Synthetic substance, no natural derivative
IUPAC Logo
Phenadoxone image
Phenadoxone, an opioid analgesic, was developed in the 20th century. It is used for pain management and is part of the broader opioid research landscape. Its role in pain management is noted for its effectiveness, though it has been less prominent compared to newer opioids.
Synthetic Substances Image
Phenadoxone is an opioid analgesic with potent pain-relieving properties. It causes sedation, respiratory depression, and constricted pupils. Short-term use provides effective pain management, while long-term use may lead to addiction and respiratory issues. Overdose risks include severe respiratory depression and potential death. Safe use requires careful dosing and medical supervision. Recent research highlights its potency and the significant risks associated with its use.
N/A
Phenadoxone, an opioid analgesic, affects opioid receptors, causing euphoria and cognitive impairment. Immediate effects include mood enhancement and pain relief, while long-term use can lead to dependence and psychological issues such as depression. Effects last several hours, with chronic use linked to significant mental health disturbances.
N/A
Phenadoxone is a synthetic opioid, similar in action to other opioid analgesics. Its cultural significance is primarily tied to its role in pain management and the broader context of opioid use in medicine. Media coverage often focuses on the opioid crisis and the challenges associated with managing potent opioids like phenadoxone. The substance is used medicinally, though its association with opioid dependence and abuse brings it into discussions about drug policy, addiction treatment, and public health.
N/A